Abstract:Zika virus (ZIKV) is a mosquito-borne flavivirus that causes severe neurological disorders, such as microcephaly in fetuses. Most recently, an outbreak of ZIKV started in Brazil in 2015. To date, no therapeutic agents have been approved to treat ZIKV infection in the clinic. Here, we screened a small molecule inhibitor that can inhibit the function of ZIKV non-structural protein 2B (NS2B)-NS3 protease (ZIKV NS2B-NS3 protease), thereby interfering with viral replication and spread. First, we identified the half maximal inhibitory concentration (IC 50 ) of compound 3 (14.01 μM), 8 (6.85 μM), and 9 (14.2 μM) and confirmed that they are all non-competitive inhibitors. In addition, we have used the blind molecular docking method to simulate the inhibition area of three non-competitive inhibitors (compound 3, 8, and 9) with the ZIKV NS2B-NS3 protease. The results indicated that the four allosteric binding residues (Gln139, Trp148, Leu150, and Val220) could form hydrogen bonds or non-bonding interactions most frequently with the three compounds. The interaction might induce the reaction center conformation change of NS2B-NS3 protease to reduce catalyzed efficiency. The concentration of compounds required to reduce cell viability by 50% (CC 50 ), and the concentration of compounds required to inhibit virus-induced cytopathic effect by 50% (EC 50 ) of three potential compounds are >200 μM, 2.15 μM (compound 3), > 200 μM, 0.52 μM (compound 8) and 61.48 μM, 3.52 μM (compound 9), and Temoporfin are 61.05 μM, 2 μM, respectively. To select candidate compounds for further animal experiments, we analyzed the selectivity index (SI) of compound 3 (93.02), 8 (384.61), 9 (17.46), and Temoporfin (30.53, FDA-approved drug against cancer). Compound 8 has the highest SI value. Therefore, compound 8 was selected for verification in animal models. In vivo, compound 8 significantly delayed ZIKV-induced lethality and illness symptoms and decreased ZIKV-induced weight loss in a ZIKV-infected suckling mouse model. We conclude that compound 8 is worth further investigation for use as a potential future therapeutic agent against ZIKV infection.

Generation of A Stable GFP-reporter Zika Virus System for High-throughput Screening of Zika Virus Inhibitors

A Cell-Based Assay to Discover Inhibitors of Zika Virus RNA-dependent RNA Polymerase

Identification Of Novel Natural Products As Effective And Broad-Spectrum Anti-Zika Virus Inhibitors

A cell-based assay to discover inhibitors of Zika virus RNA-dependent RNA polymerase.

An Antiviral Drug Screening Platform Based on Zika Replicon

Discovery And Computational Analyses Of Novel Small Molecule Zika Virus Inhibitors

Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction

Development of NS2B-NS3 protease inhibitor that impairs Zika virus replication

High-throughput crystallographic fragment screening of Zika virus NS3 Helicase

Design, synthesis, and antiviral activity of 1-aryl-4-arylmethylpiperazine derivatives as Zika virus inhibitors with broad antiviral spectrum

Construction of an infectious clone of Zika virus stably expressing an EGFP marker in a eukaryotic expression system

Identification of novel anti-ZIKV drugs from viral-infection temporal gene expression profiles

Design, Synthesis, and Biological Evaluation of Novel 2'-Methyl-2'-fluoro-6-methyl-7-alkynyl-7-deazapurine Nucleoside Analogs As Anti-Zika Virus Agents.

Design, Synthesis, and Biological Evaluation of a Series of New Anthraquinone Derivatives As Anti-Zikv Agents.

Identification of NS2B-NS3 Protease Inhibitors for Therapeutic Application in ZIKV Infection: A Pharmacophore-Based High-Throughput Virtual Screening and MD Simulations Approaches

Cathelicidin-Derived Antimicrobial Peptides Inhibit Zika Virus Through Direct Inactivation and Interferon Pathway.

Generation and characterization of Japanese encephalitis virus expressing GFP reporter gene for high throughput drug screening

The Screening of Phytochemicals Against NS5 Polymerase to Treat Zika Virus Infection: Integrated Computational Based Approach

Insight into the Natural Biomolecules (BMs): Promising Candidates as Zika Virus Inhibitors

Zika Virus Targeting by Screening Inhibitors against NS2B/NS3 Protease.

Identification of Theaflavin-3,3’-Digallate as a Novel Zika Virus Protease Inhibitor